Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reconsidering the role of blood-brain barrier in Alzheimer’s disease: From delivery to target
João André Sousa, Catarina Bernardes, Sara Bernardo-Castro, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Blood–Brain Barrier Breakdown in Alzheimer’s Disease: Mechanisms and Targeted Strategies
Amer E. Alkhalifa, Nour F. Al-Ghraiybah, Julia Odum, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16288-16288
Open Access | Times Cited: 67
The microbiota–gut–brain axis in Huntington's disease: pathogenic mechanisms and therapeutic targets
Millicent N. Ekwudo, Carolina Gubert, Anthony J. Hannan
FEBS Journal (2024)
Open Access | Times Cited: 19
Advancing neurological disorders therapies: Organic nanoparticles as a key to blood-brain barrier penetration
Zahra Razavi, Seyed Sina Alizadeh, F. S. Razavi, et al.
International Journal of Pharmaceutics (2025) Vol. 670, pp. 125186-125186
Open Access | Times Cited: 8
The Crucial Role of the Blood–Brain Barrier in Neurodegenerative Diseases: Mechanisms of Disruption and Therapeutic Implications
Sehwan Kim, Un Ju Jung, Sang Ryong Kim
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 386-386
Open Access | Times Cited: 5
Amyloid-β and heart failure in Alzheimer’s disease: the new vistas
Hayder M. Al‐kuraishy, Ghassan M. Sulaiman, Hamdoon A. Mohammed, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access | Times Cited: 4
Understanding glucose metabolism and insulin action at the blood–brain barrier: Implications for brain health and neurodegenerative diseases
Yiyi Zhu, Alexei Verkhratsky, Hui Chen, et al.
Acta Physiologica (2025) Vol. 241, Iss. 2
Open Access | Times Cited: 2
Unveiling the impact of aging on BBB and Alzheimer's disease: Factors and therapeutic implications
Niraj Kumar Jha, Niraj Kumar Jha, Mohana Vamsi Nuli, et al.
Ageing Research Reviews (2024) Vol. 98, pp. 102224-102224
Closed Access | Times Cited: 14
[125I]IPC-Lecanemab: Synthesis and Evaluation of Aβ-Plaque-Binding Antibody and Comparison with Small-Molecule [18F]Flotaza and [125I]IBETA in Postmortem Human Alzheimer’s Disease
Christopher Liang, Cayz G. Paclibar, Noresa L. Gonzaga, et al.
Neurology International (2024) Vol. 16, Iss. 2, pp. 419-431
Open Access | Times Cited: 7
Research progress in Alzheimer's disease and bone-brain axis
Fan Zhang, Wei Zhang
Ageing Research Reviews (2024) Vol. 98, pp. 102341-102341
Open Access | Times Cited: 6
Advancements and Challenges in Antiamyloid Therapy for Alzheimer’s Disease: A Comprehensive Review
Semira Abdi Beshir, Nadia Hussain, Vineetha Bharathan Menon, et al.
International Journal of Alzheimer s Disease (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 6
Post-Ischemic Permeability of the Blood–Brain Barrier to Amyloid and Platelets as a Factor in the Maturation of Alzheimer’s Disease-Type Brain Neurodegeneration
Ryszard Pluta, Barbara Miziak, Stanisław J. Czuczwar
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10739-10739
Open Access | Times Cited: 13
Blockade of A2AR improved brain perfusion and cognitive function in a mouse model of Alzheimer’s disease
Mariana Sayuri Berto Udo, Julia Zaccarelli‐Magalhães, Garrett A. Clemons, et al.
GeroScience (2025)
Closed Access
Short-chain fatty acids in Huntington's disease: Mechanisms of action and their therapeutic implications
Mohamed J. Saadh, Hanan Hassan Ahmed, Radhwan Abdul Kareem, et al.
Pharmacology Biochemistry and Behavior (2025), pp. 173972-173972
Closed Access
Neurostimulation devices to treat Alzheimer’s disease
Felipe P. Perez, Brett S. Walker, Jorge Morisaki, et al.
Exploration of neuroscience (2025)
Open Access
Adipose tissue as a therapeutic target for vascular damage in Alzheimer's disease
Miriam Bettinetti‐Luque, Laura Trujillo‐Estrada, Eduardo García‐Fuentes, et al.
British Journal of Pharmacology (2023) Vol. 181, Iss. 6, pp. 840-878
Open Access | Times Cited: 10
Patient-Derived Blood-Brain Barrier Model for Screening Copper Bis(thiosemicarbazone) Complexes as Potential Therapeutics in Alzheimer’s Disease
Joanna M. Wasielewska, Kathryn Szostak, Lachlan E. McInnes, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 7, pp. 1432-1455
Open Access | Times Cited: 3
Synthesis and Characterization of Memantine-Loaded Niosomes for Enhanced Alzheimer’s Disease Targeting
Hasan Türkez, Sena Öner, Özge Çağlar, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 267-267
Open Access
Blood–brain barrier disruption: a pervasive driver and mechanistic link between traumatic brain injury and Alzheimer's disease
Bryan Sun, Lulin Li, Odette A. Harris, et al.
Translational Neurodegeneration (2025) Vol. 14, Iss. 1
Open Access
Recent advances in brain delivery of synthetic and natural nano therapeutics: Reviving hope for Alzheimer's disease patients
Doaa Sayed Nady, Udo Bakowsky, Sherif Ashraf Fahmy
Journal of Drug Delivery Science and Technology (2023) Vol. 89, pp. 105047-105047
Open Access | Times Cited: 7
5-HT1F receptor agonism induces mitochondrial biogenesis and increases cellular function in brain microvascular endothelial cells
Natalie E. Scholpa, Epiphani C. Simmons, Austin Thompson, et al.
Frontiers in Cellular Neuroscience (2024) Vol. 18
Open Access | Times Cited: 2
Astrocytic-derived vascular remodeling factors are independently associated with blood brain barrier permeability in Alzheimer’s disease
Francesca Bernocchi, Chiara Giuseppina Bonomi, Martina Assogna, et al.
Neurobiology of Aging (2024) Vol. 141, pp. 66-73
Open Access | Times Cited: 2
Nose to brain delivery for the treatment of Alzheimer's disease
Dignesh Khunt, Sagar Salave, Dhwani Rana, et al.
Elsevier eBooks (2024), pp. 61-71
Closed Access | Times Cited: 1
Type 3 Diabetes Mellitus, Insulin Resistance, Alzheimer’s Disease and Role of Alpha-Linolenic Acid in Blood–Brain Barrier Repair
Anand A. Zanwar, Asavari Joshi, Prajakta S. Gaikwad, et al.
Chronicle of Diabetes Research and Practice (2024) Vol. 3, Iss. 2, pp. 64-71
Closed Access | Times Cited: 1
Substance Delivery across the Blood-Brain Barrier or the Blood-Retinal Barrier Using Organic Cation Transporter Novel Type 2 (OCTN2)
Toshihiko Tashima
Future Pharmacology (2024) Vol. 4, Iss. 3, pp. 479-493
Open Access | Times Cited: 1
Behavioral and Biochemical Effects of an Arylhydrazone Derivative of 5-Methoxyindole-2-Carboxylic Acid in a Scopolamine-Induced Model of Alzheimer’s Type Dementia in Rats
Polina Petkova‐Kirova, Neda Anastassova, Borislav Minchev, et al.
Molecules (2024) Vol. 29, Iss. 23, pp. 5711-5711
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top